Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study.
Hepatitis B
Hepatitis B vaccination
Mass vaccination
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
20 Mar 2024
20 Mar 2024
Historique:
received:
25
10
2023
accepted:
11
03
2024
medline:
21
3
2024
pubmed:
21
3
2024
entrez:
21
3
2024
Statut:
epublish
Résumé
Hepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention. A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vaccination. This study aims to determine the uptake and completion of HBV vaccination and associated factors among residents of Gulu, Uganda. A mixed methods cross-sectional study was conducted in Gulu, Northern Uganda, among 434 adult residents. A pretested questionnaire was used to collect data on socio-demographics, perceptions, and knowledge of HBV vaccination. Modified Poisson regression analysis was used in STATA 14 software to obtain prevalence ratios for the association between the independent and dependent variables. For qualitative data, 9 key informant interviews were conducted and thematic analysis was done using Quirkos software. Out of the 434 respondents, 41.9% had received at least one dose of the hepatitis B vaccine, 32.5% had received at least 2 doses, and only 20% had completed all 3 doses, with an overall completion rate of 47.8% for participants who had been initiated on the vaccine. Gender, residence, risk perception of Hepatitis B infection, perceived safety of the vaccine, and awareness of mass vaccination were associated with uptake of Hepatitis B vaccination. Residence, knowledge, and perception of being at risk of acquiring Hepatitis B were associated with completion. Qualitative results revealed that the levels of uptake and completion could have been affected by access to vaccination sites; inadequate knowledge about the disease; myths about the vaccine and inadequate community engagement. Low Hepatitis B vaccine uptake and completion rates were observed in Gulu. To enhance vaccination coverage, future initiatives should prioritize awareness, education, and dispelling of vaccination myths. Additionally, increased government investment in training health workers can serve as a valuable strategy to improve information dissemination and awareness among the population.
Sections du résumé
BACKGROUND
BACKGROUND
Hepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention. A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vaccination. This study aims to determine the uptake and completion of HBV vaccination and associated factors among residents of Gulu, Uganda.
METHODS
METHODS
A mixed methods cross-sectional study was conducted in Gulu, Northern Uganda, among 434 adult residents. A pretested questionnaire was used to collect data on socio-demographics, perceptions, and knowledge of HBV vaccination. Modified Poisson regression analysis was used in STATA 14 software to obtain prevalence ratios for the association between the independent and dependent variables. For qualitative data, 9 key informant interviews were conducted and thematic analysis was done using Quirkos software.
RESULTS
RESULTS
Out of the 434 respondents, 41.9% had received at least one dose of the hepatitis B vaccine, 32.5% had received at least 2 doses, and only 20% had completed all 3 doses, with an overall completion rate of 47.8% for participants who had been initiated on the vaccine. Gender, residence, risk perception of Hepatitis B infection, perceived safety of the vaccine, and awareness of mass vaccination were associated with uptake of Hepatitis B vaccination. Residence, knowledge, and perception of being at risk of acquiring Hepatitis B were associated with completion. Qualitative results revealed that the levels of uptake and completion could have been affected by access to vaccination sites; inadequate knowledge about the disease; myths about the vaccine and inadequate community engagement.
CONCLUSION
CONCLUSIONS
Low Hepatitis B vaccine uptake and completion rates were observed in Gulu. To enhance vaccination coverage, future initiatives should prioritize awareness, education, and dispelling of vaccination myths. Additionally, increased government investment in training health workers can serve as a valuable strategy to improve information dissemination and awareness among the population.
Identifiants
pubmed: 38509496
doi: 10.1186/s12889-024-18330-2
pii: 10.1186/s12889-024-18330-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
866Informations de copyright
© 2024. The Author(s).
Références
Razavi-Shearer D, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Volume 3. The lancet Gastroenterology & hepatology; 2018. pp. 383–403. 6.
Spearman CW, et al. Hepatitis B in sub-saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900–9.
doi: 10.1016/S2468-1253(17)30295-9
pubmed: 29132759
Organization WH. Global hepatitis report 2017: executive summary. World Health Organization; 2017.
Ssekamatte T, et al. Distribution of Hepatitis B prevention services in Wakiso District, Central Uganda. PLOS Global Public Health. 2023;3(9):e0000478.
doi: 10.1371/journal.pgph.0000478
pubmed: 37738234
pmcid: 10516414
Bwogi J et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci, 2009. 9(2).
Meenakshi, Dalal. Uganda elevates health for all with free hepatitis testing, treatment and vaccines. WHO Africa region; 2023. p. 72.
Stanaway JD, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of Disease Study 2013. Lancet. 2016;388(10049):1081–8.
doi: 10.1016/S0140-6736(16)30579-7
pubmed: 27394647
pmcid: 5100695
Organization WH. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus, in Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. 2021.
T MoH. Annual Health Sector Performance Report. 2016.
Uganda Moh. World hepatitis day 2018: Report 2016 Uganda Population-based HIV Impact Assessment (UPHIA) Survey: press statement on the progress of implementation of hepatitis b vaccination program in Uganda Hon, 2018.
Commission UA. Uganda population based HIV impact assessment. Volume UAC. Uganda: Kampala; 2017. pp. 62–5.
Odele S. Determinants Of Hepatitis B Vaccine Uptake Among Adults In Soroti Municipality, Soroti District 2017.
Baruch Y. Response rate in academic studies-A comparative analysis. Hum Relat. 1999;52(4):421–38.
doi: 10.1177/001872679905200401
UDHS, Uganda Demographic and Health Survey 2016: Key indicators Report. 2016, Uganda Bureau of Statistcs (UBOS), and ICF Rockville, Maryland, USA: Kampala, Uganda.
Jones CJ, Smith H, Llewellyn C. Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review. Health Psychol Rev. 2014;8(3):253–69.
doi: 10.1080/17437199.2013.802623
pubmed: 25053213
Omotowo I, et al. Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria. Volume 18. BMC infectious diseases; 2018. pp. 1–9. 1.
Feleke BE. Low coverage of hepatitis B vaccine and determinants among health professionals working in Amhara regional state hospitals, Ethiopia. J Public Health Afr, 2016. 7(2).
Osei E, Niyilapah J, Kofi Amenuvegbe G. Hepatitis B knowledge, testing, and vaccination history among undergraduate public health students in Ghana BioMed research international, 2019. 2019.
Taylor JE, et al. Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study. BMC Infect Dis. 2019;19:1–9.
doi: 10.1186/s12879-019-3926-2
Ssekamatte T, et al. Hepatitis B screening and vaccination status of healthcare providers in Wakiso district, Uganda. PLoS ONE. 2020;15(7):e0235470.
doi: 10.1371/journal.pone.0235470
pubmed: 32645078
pmcid: 7347299
Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health. 2019;19(1):1–9.
doi: 10.1186/s12889-019-6693-5
Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ open. 2017;7(5):e015845.
doi: 10.1136/bmjopen-2017-015845
pubmed: 28576900
pmcid: 5541342
Chingle M, et al. Risk perception of hepatitis B infection and uptake of hepatitis B vaccine among students of tertiary institution in Jos. Ann Afr Med. 2017;16(2):59.
doi: 10.4103/aam.aam_49_16
pubmed: 28469118
pmcid: 5452710
Meriki HD, et al. Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon. PLoS ONE. 2018;13(7):e0200157.
doi: 10.1371/journal.pone.0200157
pubmed: 30011286
pmcid: 6047772
Aroke D et al. Awareness and vaccine coverage of hepatitis B among Cameroonian medical students BioMed research international, 2018. 2018.
KENYA HI. Leah Jepkios Bett (HND). Kenyatta University; 2014.